A Study of Lacutoclax (LP-108) in Patients With Relapsed/Refractory CLL/SLL
Clinical trial NCT07609823 · RECRUITING
Trial details
- NCT number
- NCT07609823
- Sponsor
- Guangzhou Lupeng Pharmaceutical Company LTD.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-14
- Primary completion
- 2028-03-30
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.